MDT
stock Healthcare Medical DevicesOverall Mixed · 60%
- Fundamentals Strong
- Trajectory Steady
- Leadership Churning
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Mixed 2 of 5 trend signals bullishRSI 54 — momentum is balanced between buyers and sellers.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 10
- Open
- $82.21
- +0.28%
- Close
- $80.31
- -2.04%
- Current
- $80.31
- Prev close
- $81.98
- Today
- 5.33M
- 3-mo avg
- 9.78M
Earningscalendar synced from Yahoo 40d ago
- Most recent
- Jun 348 days ago
- Next expected
- Aug 18in 28 days
Recent earnings dates
- Jun 3 48 days ago
- Feb 17 154 days ago
- Nov 18, 2025 245 days ago
- Aug 19, 2025 336 days ago
Past earnings dates come from MDT’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 40d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Jan 2026 earnings, against the latest price), MDT’s fundamentals read as strong overall.
Latest SEC earnings are from Jan 2026; the price-based ratios may lag a more recent quarter.
At 22.4x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 3.5% yield is a healthy, generally sustainable level of cash income.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 13.9% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 9.7% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 5.1% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 0.90, the company carries less in liabilities than in equity, a conservative balance sheet.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.85, short-term assets comfortably cover short-term bills.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 3.6% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 26.8% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 40d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $30.1B | $31.7B | $31.2B | $32.4B | $33.5B |
| Net income | $3.6B | $5.0B | $3.8B | $3.7B | $4.7B |
| Diluted EPS | $2.66 | $3.73 | $2.82 | $2.76 | $3.61 |
| Dividend / share | $2.32 | $2.52 | $2.72 | $2.76 | $2.80 |
| Total assets | $93.1B | $91.0B | $90.9B | $90.0B | $91.7B |
| Total liabilities | $41.5B | $38.3B | $39.3B | $39.6B | $43.4B |
| Shareholder equity | $51.6B | $52.7B | $51.7B | $50.2B | $48.0B |
| Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.6B | $7.9B | $8.4B | $8.3B | $8.9B | $8.6B | $9.0B | $9.0B |
| Net income | $654.0M | $1.0B | $1.3B | $1.3B | $1.1B | $1.0B | $1.4B | $1.1B |
| Diluted EPS | $0.50 | $0.80 | $0.99 | $1.01 | $0.81 | $0.81 | $1.07 | $0.89 |
| Dividend / share | $0.69 | $0.70 | $0.70 | $0.70 | $0.70 | $0.71 | $0.71 | $0.71 |
Leadershipsynced from SEC 40d ago
- Martha Geoffrey Chairman and CEO · Director
- Pieton Thierry EVP & Chief Financial Officer
- Blomquist Denise L. Chief Accounting Officer
- Kiil Harry Skip EVP & President Cardiovascular
- Marinaro Michael EVP, Pres MedSurg and Americas
- Smith Gregory L EVP Global Ops & Supply Chain
- Wall Brett A. EVP & Pres Neuroscience
- Walter Matthew R. SVP, Chief HR Officer
- Arnold Craig Director
- Donnelly Scott C Director
- Fonseca Lidia Director
- Groetelaars John P Director
- Hogan Randall J Director
- Jellison William R Director
- Lee Joon Sup Director
- Lewis Gregory P Director
- Lofton Kevin E Director
- Nabel Elizabeth G Director
- Powell Kendall J Director
Officers and board are drawn from MDT’s recent SEC ownership filings (Forms 3, 4 and 5).
Notable recent eventspast year
- Jun 4 +5.1% one-day move
- Jun 3 +5.7% one-day move
- May 18 Officer or director change reported in an 8-K
- Apr 28 New 6-month low (-22% off peak)
- Mar 10 New 6-month low (-15% off peak)
- Nov 3, 2025 Officer or director change reported in an 8-K
- Aug 19, 2025 Officer or director change reported in an 8-K
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 40d ago
- 2025 total
- $2.83
- 2026 so far
- $0.711 payment
- 2026 projected
- $2.84+0.4% vs 2025
Projection scales MDT’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- Mar 27 $0.71
- Dec 26, 2025 $0.71
- Sep 26, 2025 $0.71
- Jun 27, 2025 $0.71
- Mar 28, 2025 $0.70
- Dec 27, 2024 $0.70
- Sep 27, 2024 $0.70
- Jun 28, 2024 $0.70
- Mar 21, 2024 $0.69
- Dec 19, 2023 $0.69
- Sep 21, 2023 $0.69
- Jun 22, 2023 $0.69
- Mar 23, 2023 $0.68
- Dec 20, 2022 $0.68
- Sep 22, 2022 $0.68
- Jun 23, 2022 $0.68
- Mar 24, 2022 $0.63
- Dec 21, 2021 $0.63
- Sep 23, 2021 $0.63
- Jun 24, 2021 $0.63
Recent SEC filingssynced from SEC 40d ago
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report
- 10-K Annual report
- 8-K Current report